nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1A2—Cyclosporine—focal segmental glomerulosclerosis	0.143	0.167	CbGbCtD
Lovastatin—SLCO1B1—Cyclosporine—focal segmental glomerulosclerosis	0.135	0.157	CbGbCtD
Lovastatin—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.118	0.138	CbGbCtD
Lovastatin—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0791	0.0924	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0791	0.0924	CbGbCtD
Lovastatin—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0593	0.0693	CbGbCtD
Lovastatin—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0571	0.0666	CbGbCtD
Lovastatin—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0479	0.0559	CbGbCtD
Lovastatin—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0398	0.0465	CbGbCtD
Lovastatin—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0386	0.0451	CbGbCtD
Lovastatin—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0364	0.0425	CbGbCtD
Lovastatin—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0231	0.027	CbGbCtD
Lovastatin—ITGAL—endothelium—focal segmental glomerulosclerosis	0.0149	0.264	CbGeAlD
Lovastatin—ITGAL—Integrin cell surface interactions—COL4A4—focal segmental glomerulosclerosis	0.00395	0.0676	CbGpPWpGaD
Lovastatin—ITGAL—Integrin cell surface interactions—COL4A1—focal segmental glomerulosclerosis	0.00363	0.0621	CbGpPWpGaD
Lovastatin—ITGAL—Integrin cell surface interactions—COL4A3—focal segmental glomerulosclerosis	0.00306	0.0525	CbGpPWpGaD
Lovastatin—UGT2B7—kidney—focal segmental glomerulosclerosis	0.00293	0.0519	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00293	0.0518	CbGeAlD
Lovastatin—ITGAL—Beta2 integrin cell surface interactions—CD40LG—focal segmental glomerulosclerosis	0.00279	0.0477	CbGpPWpGaD
Lovastatin—HDAC2—nephron tubule—focal segmental glomerulosclerosis	0.00273	0.0484	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00251	0.0444	CbGeAlD
Lovastatin—UGT1A1—kidney—focal segmental glomerulosclerosis	0.00249	0.0441	CbGeAlD
Lovastatin—HMGCR—nephron tubule—focal segmental glomerulosclerosis	0.00246	0.0436	CbGeAlD
Lovastatin—HDAC2—kidney—focal segmental glomerulosclerosis	0.0024	0.0425	CbGeAlD
Lovastatin—HDAC2—cortex of kidney—focal segmental glomerulosclerosis	0.00234	0.0414	CbGeAlD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—ANGPT2—focal segmental glomerulosclerosis	0.00227	0.0389	CbGpPWpGaD
Lovastatin—HMGCR—kidney—focal segmental glomerulosclerosis	0.00217	0.0383	CbGeAlD
Lovastatin—HMGCR—cortex of kidney—focal segmental glomerulosclerosis	0.00211	0.0373	CbGeAlD
Lovastatin—SLCO1B1—kidney—focal segmental glomerulosclerosis	0.00208	0.0367	CbGeAlD
Lovastatin—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.00179	0.0317	CbGeAlD
Lovastatin—HMGCR—Statin Pathway—LIPC—focal segmental glomerulosclerosis	0.00172	0.0295	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—COL4A4—focal segmental glomerulosclerosis	0.00169	0.029	CbGpPWpGaD
Lovastatin—SLCO1A2—kidney—focal segmental glomerulosclerosis	0.00169	0.0299	CbGeAlD
Lovastatin—ABCC2—kidney—focal segmental glomerulosclerosis	0.00157	0.0279	CbGeAlD
Lovastatin—HDAC2—Hedgehog signaling events mediated by Gli proteins—PIAS1—focal segmental glomerulosclerosis	0.00156	0.0268	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—COL4A1—focal segmental glomerulosclerosis	0.00156	0.0267	CbGpPWpGaD
Lovastatin—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.00153	0.0271	CbGeAlD
Lovastatin—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.0487	CcSEcCtD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD40LG—focal segmental glomerulosclerosis	0.00138	0.0236	CbGpPWpGaD
Lovastatin—ITGAL—Integrin cell surface interactions—SPP1—focal segmental glomerulosclerosis	0.00134	0.023	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.0013	0.0223	CbGpPWpGaD
Lovastatin—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00121	0.0215	CbGeAlD
Lovastatin—ITGAL—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.0012	0.0205	CbGpPWpGaD
Lovastatin—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00118	0.0209	CbGeAlD
Lovastatin—ITGAL—Integrin cell surface interactions—FN1—focal segmental glomerulosclerosis	0.00112	0.0192	CbGpPWpGaD
Lovastatin—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0386	CcSEcCtD
Lovastatin—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00106	0.0189	CbGeAlD
Lovastatin—HMGCR—Statin Pathway—LPL—focal segmental glomerulosclerosis	0.00105	0.018	CbGpPWpGaD
Lovastatin—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00104	0.0184	CbGeAlD
Lovastatin—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0359	CcSEcCtD
Lovastatin—ITGAL—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.00101	0.0173	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00092	0.0158	CbGpPWpGaD
Lovastatin—SLCO1A2—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000905	0.0155	CbGpPWpGaD
Lovastatin—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.000878	0.0306	CcSEcCtD
Lovastatin—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000815	0.0284	CcSEcCtD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—FN1—focal segmental glomerulosclerosis	0.00081	0.0139	CbGpPWpGaD
Lovastatin—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000799	0.0141	CbGeAlD
Lovastatin—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000797	0.0277	CcSEcCtD
Lovastatin—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.000793	0.0276	CcSEcCtD
Lovastatin—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000786	0.0139	CbGeAlD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000782	0.0134	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—WT1—focal segmental glomerulosclerosis	0.000782	0.0134	CbGpPWpGaD
Lovastatin—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000775	0.027	CcSEcCtD
Lovastatin—SLCO1B1—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000774	0.0133	CbGpPWpGaD
Lovastatin—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000739	0.0257	CcSEcCtD
Lovastatin—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000733	0.0255	CcSEcCtD
Lovastatin—SLCO1A2—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000671	0.0115	CbGpPWpGaD
Lovastatin—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000644	0.0114	CbGeAlD
Lovastatin—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000642	0.0223	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000616	0.0106	CbGpPWpGaD
Lovastatin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000604	0.021	CcSEcCtD
Lovastatin—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000591	0.0205	CcSEcCtD
Lovastatin—ITGAL—Focal Adhesion—SPP1—focal segmental glomerulosclerosis	0.000576	0.00987	CbGpPWpGaD
Lovastatin—SLCO1B1—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000573	0.00982	CbGpPWpGaD
Lovastatin—ABCB1—kidney—focal segmental glomerulosclerosis	0.000566	0.01	CbGeAlD
Lovastatin—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000551	0.00975	CbGeAlD
Lovastatin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000538	0.0187	CcSEcCtD
Lovastatin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000534	0.0186	CcSEcCtD
Lovastatin—HMGCR—SREBP signalling—LPL—focal segmental glomerulosclerosis	0.000526	0.00901	CbGpPWpGaD
Lovastatin—HMGCR—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000522	0.00895	CbGpPWpGaD
Lovastatin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000515	0.0179	CcSEcCtD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000511	0.00876	CbGpPWpGaD
Lovastatin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.0171	CcSEcCtD
Lovastatin—ITGAL—Focal Adhesion—FN1—focal segmental glomerulosclerosis	0.000481	0.00823	CbGpPWpGaD
Lovastatin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000458	0.0159	CcSEcCtD
Lovastatin—ITGAL—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000443	0.00758	CbGpPWpGaD
Lovastatin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000442	0.0154	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000442	0.00757	CbGpPWpGaD
Lovastatin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000436	0.0152	CcSEcCtD
Lovastatin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000423	0.0147	CcSEcCtD
Lovastatin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00042	0.0146	CcSEcCtD
Lovastatin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000413	0.0144	CcSEcCtD
Lovastatin—ITGAL—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000406	0.00695	CbGpPWpGaD
Lovastatin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000404	0.0141	CcSEcCtD
Lovastatin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000402	0.014	CcSEcCtD
Lovastatin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000398	0.0139	CcSEcCtD
Lovastatin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.0136	CcSEcCtD
Lovastatin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000387	0.0135	CcSEcCtD
Lovastatin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000386	0.0134	CcSEcCtD
Lovastatin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000384	0.0134	CcSEcCtD
Lovastatin—ITGAL—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000369	0.00633	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000369	0.00632	CbGpPWpGaD
Lovastatin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.0127	CcSEcCtD
Lovastatin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.0127	CcSEcCtD
Lovastatin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.0127	CcSEcCtD
Lovastatin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000364	0.0127	CcSEcCtD
Lovastatin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.0126	CcSEcCtD
Lovastatin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000357	0.0124	CcSEcCtD
Lovastatin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000353	0.0123	CcSEcCtD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000352	0.00603	CbGpPWpGaD
Lovastatin—SLCO1A2—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000351	0.006	CbGpPWpGaD
Lovastatin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00035	0.0122	CcSEcCtD
Lovastatin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000348	0.0121	CcSEcCtD
Lovastatin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000343	0.0119	CcSEcCtD
Lovastatin—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000336	0.00575	CbGpPWpGaD
Lovastatin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.0116	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000319	0.0111	CcSEcCtD
Lovastatin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000317	0.011	CcSEcCtD
Lovastatin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.0109	CcSEcCtD
Lovastatin—ITGAL—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000313	0.00537	CbGpPWpGaD
Lovastatin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.0109	CcSEcCtD
Lovastatin—HMGCR—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00031	0.00531	CbGpPWpGaD
Lovastatin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000308	0.0107	CcSEcCtD
Lovastatin—ITGAL—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.000307	0.00527	CbGpPWpGaD
Lovastatin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000304	0.0106	CcSEcCtD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000303	0.00519	CbGpPWpGaD
Lovastatin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000302	0.0105	CcSEcCtD
Lovastatin—ITGAL—Immune System—MYH9—focal segmental glomerulosclerosis	0.0003	0.00515	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.0003	0.00514	CbGpPWpGaD
Lovastatin—SLCO1B1—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.0003	0.00514	CbGpPWpGaD
Lovastatin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.0104	CcSEcCtD
Lovastatin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.0104	CcSEcCtD
Lovastatin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000289	0.01	CcSEcCtD
Lovastatin—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000287	0.00492	CbGpPWpGaD
Lovastatin—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000287	0.00492	CbGpPWpGaD
Lovastatin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00996	CcSEcCtD
Lovastatin—HDAC2—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000286	0.0049	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000283	0.00485	CbGpPWpGaD
Lovastatin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000278	0.00968	CcSEcCtD
Lovastatin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00963	CcSEcCtD
Lovastatin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00963	CcSEcCtD
Lovastatin—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000264	0.00452	CbGpPWpGaD
Lovastatin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00898	CcSEcCtD
Lovastatin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000251	0.00874	CcSEcCtD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—focal segmental glomerulosclerosis	0.00025	0.00429	CbGpPWpGaD
Lovastatin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000248	0.00862	CcSEcCtD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000246	0.00422	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000245	0.00419	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—SERPINE1—focal segmental glomerulosclerosis	0.000243	0.00417	CbGpPWpGaD
Lovastatin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00024	0.00834	CcSEcCtD
Lovastatin—HDAC2—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.000237	0.00407	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	0.000235	0.00403	CbGpPWpGaD
Lovastatin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000232	0.00806	CcSEcCtD
Lovastatin—HDAC2—Direct p53 effectors—SPP1—focal segmental glomerulosclerosis	0.000226	0.00387	CbGpPWpGaD
Lovastatin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00775	CcSEcCtD
Lovastatin—HDAC2—Direct p53 effectors—PCNA—focal segmental glomerulosclerosis	0.000222	0.0038	CbGpPWpGaD
Lovastatin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00768	CcSEcCtD
Lovastatin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00768	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00022	0.00376	CbGpPWpGaD
Lovastatin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000219	0.00763	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000217	0.00372	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000209	0.00358	CbGpPWpGaD
Lovastatin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000208	0.00724	CcSEcCtD
Lovastatin—ITGAL—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	0.000194	0.00332	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000189	0.00324	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—focal segmental glomerulosclerosis	0.000188	0.00322	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000183	0.00313	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000182	0.00312	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD79A—focal segmental glomerulosclerosis	0.000182	0.00312	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	0.000177	0.00302	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00017	0.00291	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000167	0.00287	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—MMP2—focal segmental glomerulosclerosis	0.00016	0.00274	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000159	0.00273	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—SERPINE1—focal segmental glomerulosclerosis	0.000157	0.00269	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000148	0.00254	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000148	0.00254	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000145	0.00249	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00014	0.0024	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00014	0.00239	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000136	0.00233	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—TGFB1—focal segmental glomerulosclerosis	0.000128	0.00219	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000124	0.00213	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000118	0.00201	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000115	0.00198	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000113	0.00194	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000111	0.00189	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.00011	0.00188	CbGpPWpGaD
Lovastatin—UGT1A3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	9.77e-05	0.00167	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	9.72e-05	0.00167	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	9.61e-05	0.00165	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	9.26e-05	0.00159	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	8.87e-05	0.00152	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.46e-05	0.00145	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	8.32e-05	0.00142	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	8.31e-05	0.00142	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.22e-05	0.00141	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	8.08e-05	0.00138	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	8.06e-05	0.00138	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.59e-05	0.0013	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	7.41e-05	0.00127	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.24e-05	0.00124	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	7.21e-05	0.00123	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—LIPC—focal segmental glomerulosclerosis	7.09e-05	0.00122	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.75e-05	0.00116	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—FN1—focal segmental glomerulosclerosis	6.75e-05	0.00116	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NOS2—focal segmental glomerulosclerosis	6.67e-05	0.00114	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.59e-05	0.00113	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—CTGF—focal segmental glomerulosclerosis	6.42e-05	0.0011	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	6.38e-05	0.00109	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.26e-05	0.00107	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CTGF—focal segmental glomerulosclerosis	6.25e-05	0.00107	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	6.16e-05	0.00106	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.87e-05	0.00101	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—LIPC—focal segmental glomerulosclerosis	5.78e-05	0.000991	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.75e-05	0.000986	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	5.61e-05	0.000962	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ALB—focal segmental glomerulosclerosis	5.6e-05	0.00096	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	5.59e-05	0.000958	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CTGF—focal segmental glomerulosclerosis	5.09e-05	0.000872	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	5.06e-05	0.000867	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.02e-05	0.00086	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.02e-05	0.00086	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	4.92e-05	0.000842	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.72e-05	0.000809	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.69e-05	0.000804	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.6e-05	0.000788	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.58e-05	0.000784	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—LPL—focal segmental glomerulosclerosis	4.33e-05	0.000742	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	4.33e-05	0.000742	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.29e-05	0.000735	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	4.28e-05	0.000734	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.22e-05	0.000722	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.16e-05	0.000713	CbGpPWpGaD
Lovastatin—HDAC2—Disease—LPL—focal segmental glomerulosclerosis	4.13e-05	0.000708	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	4e-05	0.000685	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.99e-05	0.000683	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.85e-05	0.00066	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.85e-05	0.000659	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.84e-05	0.000659	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.8e-05	0.000651	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	3.77e-05	0.000646	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.71e-05	0.000636	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AGT—focal segmental glomerulosclerosis	3.7e-05	0.000634	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.66e-05	0.000627	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.66e-05	0.000627	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.54e-05	0.000607	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—LPL—focal segmental glomerulosclerosis	3.53e-05	0.000605	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.52e-05	0.000603	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.52e-05	0.000603	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.47e-05	0.000595	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.39e-05	0.00058	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	3.36e-05	0.000576	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.33e-05	0.000571	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.29e-05	0.000564	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.24e-05	0.000555	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS2—focal segmental glomerulosclerosis	3.23e-05	0.000553	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.22e-05	0.000552	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.13e-05	0.000537	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AGT—focal segmental glomerulosclerosis	3.02e-05	0.000517	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	3e-05	0.000514	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.98e-05	0.000511	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.97e-05	0.000509	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	2.96e-05	0.000507	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	2.93e-05	0.000502	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.89e-05	0.000496	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.88e-05	0.000494	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ALB—focal segmental glomerulosclerosis	2.84e-05	0.000487	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.74e-05	0.00047	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.73e-05	0.000467	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SERPINE1—focal segmental glomerulosclerosis	2.72e-05	0.000466	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—LPL—focal segmental glomerulosclerosis	2.61e-05	0.000448	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.57e-05	0.000441	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	2.57e-05	0.00044	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.5e-05	0.000428	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.48e-05	0.000424	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.47e-05	0.000423	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—LPL—focal segmental glomerulosclerosis	2.44e-05	0.000418	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	2.43e-05	0.000416	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.35e-05	0.000402	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ALB—focal segmental glomerulosclerosis	2.32e-05	0.000397	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.29e-05	0.000392	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.24e-05	0.000383	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—LPL—focal segmental glomerulosclerosis	2.23e-05	0.000383	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.2e-05	0.000377	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	2.14e-05	0.000366	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	2.1e-05	0.00036	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AGT—focal segmental glomerulosclerosis	2.09e-05	0.000357	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.05e-05	0.000351	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.01e-05	0.000344	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.97e-05	0.000338	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	1.97e-05	0.000337	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AGT—focal segmental glomerulosclerosis	1.91e-05	0.000327	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.9e-05	0.000326	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.89e-05	0.000324	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	1.88e-05	0.000322	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	1.85e-05	0.000317	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.83e-05	0.000314	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	1.75e-05	0.000301	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.73e-05	0.000296	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—focal segmental glomerulosclerosis	1.72e-05	0.000294	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.72e-05	0.000294	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.71e-05	0.000293	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.71e-05	0.000292	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.69e-05	0.000289	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	1.65e-05	0.000283	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.61e-05	0.000276	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.6e-05	0.000274	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.57e-05	0.000269	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.54e-05	0.000264	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.52e-05	0.000261	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.52e-05	0.000261	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.51e-05	0.000258	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.49e-05	0.000255	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	1.48e-05	0.000254	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—focal segmental glomerulosclerosis	1.47e-05	0.000251	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.46e-05	0.00025	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.4e-05	0.00024	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.39e-05	0.000238	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.35e-05	0.000231	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.28e-05	0.00022	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.27e-05	0.000217	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.2e-05	0.000206	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.15e-05	0.000196	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.13e-05	0.000193	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.12e-05	0.000192	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	1.1e-05	0.000188	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.05e-05	0.000181	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.04e-05	0.000179	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	9.94e-06	0.00017	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	9.8e-06	0.000168	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	9.73e-06	0.000167	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	9.57e-06	0.000164	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.16e-06	0.000157	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	9.02e-06	0.000154	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	8.94e-06	0.000153	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	8.43e-06	0.000144	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	7.52e-06	0.000129	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	7.34e-06	0.000126	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	6.92e-06	0.000119	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	6.89e-06	0.000118	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	6.86e-06	0.000118	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	5.9e-06	0.000101	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	4.52e-06	7.75e-05	CbGpPWpGaD
